At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 24 enrolled

Drug / intervention

celecoxib +2 moredrug

Likely dose

celecoxib 200 mgfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00565500

NCT00565500Phase 4Completed

Compare CT.gov

A Placebo-Controlled, Double-Blind, Randomized Study of the Potential Interaction Between Aspirin and Ibuprofen or Celecoxib.

University of Chieti·interventional·Posted Nov 30, 2007·Updated Nov 30, 2007

In Brief

A Phase 4 clinical trial evaluating celecoxib, ibuprofen, and 1 other intervention for Ischemic Heart Disease and Osteoarthritis. Completed, enrolled 24 participants across 1 site.

Detailed Summary

Study design: Single center, placebo-controlled, double blind, parallel groups. To evaluate the potential interaction between aspirin and ibuprofen or celecoxib in patients with osteoarthritis (OA) and documented stable ischemic heart disease, a total of 24 patients chronically treated with aspirin will be randomly assigned to one of the 3 treatment groups: 1) celecoxib 200 mg bid; 2) ibuprofen 600 mg tid; 3) placebo.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsIschemic Heart Disease, Osteoarthritis

CountriesItaly

CollaboratorsPfizer

Timeline

Phase 4CompletedFinished

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartApr 2003

Study CompletionApr 2005

First PostedNov 2007

TodayJul 2026

First PostedNov 30, 2007

Enrollment StartApr 1, 2003

Study CompletionApr 1, 2005

TodayJul 2, 2026

Posted 18.6 years ago

Interventions

celecoxibdrug

celecoxib capsules 200 mg bid for 1 week

ibuprofendrug

ibuprofen tablets 600 mg tid for 1 week

placebodrug

placebo capsules tid for 1 week